|
FOURTH ANNUAL SUMMIT ON DISCLOSURE, TRANSPARENCY AND
AGGREGATE SPEND FOR DRUG, DEVICE AND BIOTECH COMPANIES
A Pharma Congress Conference
March 26 - 28, 2012
|
ONSITE
Renaissance Hotel
Washington, DC
|
OR |
ONLINE
In your own office or home live via the Internet
with 24/7 access for six months
|
 |
|
|
|
CO CHAIRS
|
Karen Lowney
Senior Director, Compliance, Teva Pharmaceuticals, Frazer, PA |
Katherine E. Norris, MPA
Director, Corporate Compliance, The Spectranetics Corporation, Colorado Springs, CO
|
Trudy J. Seeley
Senior Manager, Transparency Operations, Sanofi US, Bridgewater, NJ |
Wendy Tsuei, MBA
Associate Director, State and Federal Reporting, Corporate Ethics and Compliance, Eisai Inc., Woodcliff Lake, NJ
|
|
|
|
|
FEATURED FACULTY
|
Danielle Bacco
Manager, Corporate Compliance, Purdue Pharma LP, Stamford, CT |
Michael Bell, Esq.
President, R-Squared, Princeton, NJ |
Jean Bicknell
Consultant, Regulatory Law, Baxter Healthcare, Deerfield, IL
|
Christine N. Bradshaw, Esq.
Director, Regulatory and Compliance Services, Porzio Pharmaceutical Services, Associate, Porzio, Bromberg & Newman, Morristown, NJ |
William E. Buzzeo, MS
Vice President and General Manager Compliance Solutions Division, Cegedim Relationship Management, Richmond, VA |
Ben Carmel
Manager, Polaris Management Partners, New York, NY
|
Louise Cashman
Senior Manager, HCP Reporting and Analysis, Boston Scientific Corporation, Boston, MA |
Jennifer Colapietro
Partner, Transparency and Aggregate Spend Practice Lead, PricewaterhouseCoopers LLP, Florham Park, NJ |
Meenakshi Datta, Esq.
Partner, Sidley Austin LLP, Chicago, IL
|
Marc Eigner, MS, MBA
Partner, Polaris Management Partners, New York, NY |
Mark Farrar
Associate Director, Navigant Consulting, Atlanta, GA |
Virginia "Ginny" A. Gibson, Esq.
Partner, Hogan Lovells US LLP, Former Executive Assistant US Attorney, Eastern District of Pennsylvania, US Department of Justice, Philadelphia, PA
|
Sarah K. Giesting, Esq.
Associate, Pharmaceutical Industry Health Regulatory Practice Group, Epstein Becker & Green, New York, NY |
Jeffrey L. Handwerker, Esq.
Partner, Arnold & Porter, Washington, DC |
Jonathon Kellerman
Principal, Pharmaceutical and Life Sciences Advisory Services, PricewaterhouseCoopers LLP, Florham Park, NJ
|
John B. Knighton, Esq.
Director and Interim Chief Compliance Officer, Wright Medical Technology, Inc., Arlington, TN |
Keith M. Korenchuk, JD, MPH
Partner, Arnold & Porter, Washington, DC |
Daniel A. Kracov, Esq.
Partner and Chair, FDA and Healthcare Practice, Arnold & Porter, Washington, DC
|
Mark Linver
Managing Director, Life Sciences Advisory Services Practice, Huron Consulting Group, LLC, New York, NY |
Seth H. Lundy, Esq.
Partner and Deputy Chair, FDA and Life Sciences Practice Group, King & Spalding LLP, Washington, DC |
Marilyn May, Esq.
Senior Litigation Counsel, US Attorney's Office, Eastern District of Pennsylvania, United States Department of Justice, Philadelphia, PA
|
Kate Whelley McCabe, Esq.
Assistant Attorney General, Public Protection Division, Vermont Office of the Attorney General, Montpelier, VT |
Jack Mitchell
Chief of Oversight and Investigations, Special Committee on Aging, United States Senate, Former Director, Commissioner's Office of Special Investigations, US Food and Drug Administration, Washington, DC |
MaryAnn Northrup, MSN
Associate Director, Navigant Consulting, Indianapolis, IN
|
Laura O'Donnell, Esq.
Chief Compliance Counsel, GE Healthcare, Wauwatosa, WI |
John Patrick Oroho, Esq.
Executive Vice President, Porzio Pharmaceutical Services Principal, Porzio, Bromberg & Newman PC, Morristown, NJ |
Amy Papranec, MBA
Vice President, Transparency, Stryker, Mahwah, NJ
|
Suj Patel
Director, Life Sciences Practice, Huron Consulting Group, New York, NY |
Tina Posey
Associate Director, Sample Compliance, Takeda Pharmaceuticals North America, Inc., Deerfield, IL |
Marjorie E. Powell, Esq.
Senior Assistant General Counsel, Pharmaceutical Research and Manufacturers of America (PhRMA), Washington, DC
|
Kelly N. (Nikki) Reeves, Esq.
Partner, King & Spalding, Washington, DC |
Tim Robinson, Esq.
President, The Regulatory Law Group, PLLC, Executive Vice President & General Counsel, MMIS, Inc., New York, NY |
Mark Scallon, MHA
Partner, Polaris Management Partners, New York, NY
|
Jack T. Tanselle
Managing Director, Navigant Consulting, Inc., Indianapolis, IN |
Manny Tzavlakis
Managing Director, Life Sciences Practice, Huron Consulting Group, New York, NY |
Jon Wilkenfeld, MBA
President, Potomac River Partners, Vienna, VA |
Julie Wind
Director - Physician Payment Reporting, Eli Lilly and Company, Indianapolis, IN |
Kim Zahan, MBA
Director R&D Financial Compliance, GlaxoSmithKline, King of Prussia, PA
|
|
|
|
|
SAVE THE DATE
|
SIXTH INTERNATIONAL PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS AND BEST PRACTICES FORUM
A Hybrid Conference and Internet Event
May 14 - 16, 2012
Hilton Budapest
Budapest, Hungary
www.InternationalPharmaCongress.com
|
|
SECOND ASIA PACIFIC PHARMACEUTICAL COMPLIANCE CONGRESS
A Hybrid Conference and Internet Event
Sponsored by Pharmaceutical Compliance Forum and Asia Pacific Healthcare Industry Compliance Team
September 11 - 13, 2012
Intercontinental Shanghai Pudong Hotel
Shanghai, China
www.AsianPharmaCongress.com
|
|
FIRST LATIN AMERICAN PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
A Hybrid Conference and Internet Event
Sponsored by Pharmaceutical Compliance Forum and Latin American Ethics and Compliance Network
October 2 - 4, 2012
Hilton Sao Paolo Morumba
Sao Paulo, Brazil
www.LatinAmericanPharmaCongress.com
|
|
THIRTEENTH PHARMACEUTICAL REGULATORY
AND COMPLIANCE CONGRESS
Sponsored by Pharmaceutical Compliance Forum
November 5 - 7, 2012
Grand Hyatt
Washington, DC
www.PharmaCongress.com
|
|
|
|
|
